245 related articles for article (PubMed ID: 11603924)
21. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
Michele DE; Gomez CA; Hong KE; Westfall MV; Metzger JM
Circ Res; 2002 Aug; 91(3):255-62. PubMed ID: 12169652
[TBL] [Abstract][Full Text] [Related]
22. Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin.
Kremneva E; Boussouf S; Nikolaeva O; Maytum R; Geeves MA; Levitsky DI
Biophys J; 2004 Dec; 87(6):3922-33. PubMed ID: 15454401
[TBL] [Abstract][Full Text] [Related]
23. Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.
Haim TE; Dowell C; Diamanti T; Scheuer J; Tardiff JC
J Mol Cell Cardiol; 2007 Jun; 42(6):1098-110. PubMed ID: 17490679
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
Bashyam MD; Savithri GR; Kumar MS; Narasimhan C; Nallari P
J Hum Genet; 2003; 48(2):55-64. PubMed ID: 12601548
[TBL] [Abstract][Full Text] [Related]
25. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
26. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
Marian AJ; Roberts R
Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
[TBL] [Abstract][Full Text] [Related]
27. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
Thierfelder L; Watkins H; MacRae C; Lamas R; McKenna W; Vosberg HP; Seidman JG; Seidman CE
Cell; 1994 Jun; 77(5):701-12. PubMed ID: 8205619
[TBL] [Abstract][Full Text] [Related]
28. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes.
Michele DE; Albayya FP; Metzger JM
Nat Med; 1999 Dec; 5(12):1413-7. PubMed ID: 10581085
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy.
Smolik S; Domal-Kwiatkowska D; Kapral M; Weglarz L
Acta Pol Pharm; 2010; 67(6):669-72. PubMed ID: 21229884
[TBL] [Abstract][Full Text] [Related]
30. alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways.
Wernicke D; Thiel C; Duja-Isac CM; Essin KV; Spindler M; Nunez DJ; Plehm R; Wessel N; Hammes A; Edwards RJ; Lippoldt A; Zacharias U; Strömer H; Neubauer S; Davies MJ; Morano I; Thierfelder L
Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R685-95. PubMed ID: 15031138
[TBL] [Abstract][Full Text] [Related]
31. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function.
Golitsina N; An Y; Greenfield NJ; Thierfelder L; Iizuka K; Seidman JG; Seidman CE; Lehrer SS; Hitchcock-DeGregori SE
Biochemistry; 1997 Apr; 36(15):4637-42. PubMed ID: 9109674
[TBL] [Abstract][Full Text] [Related]
32. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.
Fatkin D; McConnell BK; Mudd JO; Semsarian C; Moskowitz IG; Schoen FJ; Giewat M; Seidman CE; Seidman JG
J Clin Invest; 2000 Dec; 106(11):1351-9. PubMed ID: 11104788
[TBL] [Abstract][Full Text] [Related]
33. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
[TBL] [Abstract][Full Text] [Related]
34. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
[TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy.
Capek P; Brdicka R
Cas Lek Cesk; 2006; 145(2):93-6; discussion 96-7. PubMed ID: 16521396
[TBL] [Abstract][Full Text] [Related]
36. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
37. Myocardial contractile and metabolic properties of familial hypertrophic cardiomyopathy caused by cardiac troponin I gene mutations: a simulation study.
Wu B; Wang L; Liu Q; Luo Q
Exp Physiol; 2012 Jan; 97(1):155-69. PubMed ID: 21967901
[TBL] [Abstract][Full Text] [Related]
38. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
[TBL] [Abstract][Full Text] [Related]
39. The role of tropomyosin in the regulation of myocardial contraction and relaxation.
Wolska BM; Wieczorek DM
Pflugers Arch; 2003 Apr; 446(1):1-8. PubMed ID: 12690456
[TBL] [Abstract][Full Text] [Related]
40. Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift tropomyosin strands further towards the open position during the ATPase cycle.
Borovikov YS; Rysev NA; Karpicheva OE; Redwood CS
Biochem Biophys Res Commun; 2011 Apr; 407(1):197-201. PubMed ID: 21376702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
